Jean-Michel Dorey, MSc

JCP
Original Research

September 18, 2018

Cardiovascular diseases are the primary cause of mortality in individuals with schizophrenia, yet no study has yet explored the impact of metabolic syndrome on schizophrenia relapse. This study explored...
, , , et al
JCP
Original Research

April 17, 2018

The relationship between insight and suicide in patients with schizophrenia is unclear. Read this article to learn the extent to which that relationship may be influenced by quality of...
, , , et al
JCP
Original Research

September 28, 2016

Medication nonadherence among schizophrenia patients is common, but also possibly modifiable. Learn about how a patient self-report instrument—the MARS—can be used to identify nonadherence in these patients.
, , , et al
JCP
Letter to the Editor

October 15, 2010

, , , et al

Live Webinar
and Q&A With
Dr Deligiannidis

JULY 16 · REGISTER NOW
Webinar ad featuring Dr. Kristina M. Deligiannidis on PPD treatment options

Subscribe to read
more articles

Subscribe